Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
The activity of protein kinases IKK-ε and TANK-binding kinase 1 (TBK1) has been shown to be associated with inflammatory diseases. As an inhibitor of IKK-ε and TBK1, amlexanox is an anti-inflammatory, anti-allergic, immunomodulator and used for treatment of ulcer, allergic rhinitis and asthma in cli...
Main Authors: | Zhang, Yong, Guan, Hanfeng, Li, Jing, Fang, Zhong, Chen, Wenjian, Li, Feng |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559750/ |
Similar Items
-
Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways
by: Hsiao, H.-B., et al.
Published: (2012) -
Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018-09-01) -
Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis
by: Kim, Woon-Ki, et al.
Published: (2012) -
Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
by: Ke, Ke, et al.
Published: (2015) -
FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC
by: Tan, Peng, et al.
Published: (2015)